Answers are grounded in this paper and cite their sources.
Explores SF5 incorporation in bicyclobutanes, suggesting new pathways for drug design.
The recent merger of pentafluorosulfanylation with strain‐release functionalization logic—largely enabled by an increase in SF 5 Cl accessibility—has begun to reshape the ways we can imagine incorporating the SF 5 group into organic molecules. In this study, we first explore how both radical polarity matching and substituent effects, when employed synergistically, can be used to effect regio‐ and diastereoselective SF 5 Cl addition across 1,3‐disubstituted ( viz . 3‐aryl‐1‐carbonyl‐substituted) bicyclobutanes (BCBs) to access a class of congested α‐SF 5 ‐carbonyl‐containing tetrasubstituted cyclobutanes (CBs). Synthetic, computational, and structural studies provide insight on the observed selectivity and reveal unusually close intramolecular SF 5 ⋯C═X (X = C, N, or O) contacts in several SF 5 ‐CBs by SC‐XRD. Beyond accessing compounds of fundamental interest, we describe a complementary telescoped protocol to facilitate isolation of SF 5 ‐CBs as alcohols, as well as a fortuitous observation that led to the synthesis of the first suite of SF 5 ‐substituted oxa[2.1.1]bicyclohexanes (OBHs). Finally, we examine the compatibility of SF 5 ‐CBs and SF 5 ‐OBHs with various reaction conditions to expand the scope of accessible building blocks and report the synthesis of an SF 5 ‐OBH‐containing drug derivative. Results from comparative in vitro ADME profiling indicate the SF 5 ‐OBH motif may serve as an attractive “hybrid bioisostere” for the meta ‐CF 3 ‐Ph motif.
No takes yet. Share an insight, caveat, or question.
Stephens et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: